PYC
PYC Therapeutics Limited
🇦🇺 ASX
🧬 BIOTECHNOLOGY
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 43.51%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
16
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2005-03-30. The firm utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The firm's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.
📈 Performance
Price History
+812.98%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.14
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PYC
16
📊 Total Capital Earnings
$13K
🔃 Average investment frequency
32 weeks
💵 Average investment amount
$1,837
⏰ Last time a customer invested in PYC
2 days
PYC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
19%
50k - 100k
52%
Less than 50k
19%
👶 Age of investors
18 - 25
13%
26 - 34
19%
35 - 90
69%
🙋 Legal gender of investors
Female
38%
Male
63%
Pearlers who invest in PYC also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.77%
📊 Share price
$102.55 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
23.82%
📊 Share price
$43.21 AUD
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
🇺🇸 UNITED STATES
Pilbara Minerals Ltd. engages in the exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 768 full-time employees. The company went IPO on 2007-09-19. The firm is primarily engaged in the exploration, development, and mining of minerals in Australia. Its 100% owned Pilgangoora hard-rock lithium operation is located approximately 120 kilometers (kms) from Port Hedland in Western Australia’s resource-rich Pilbara region. The operation consists of two processing plants: the Pilgan Plant, located on the northern side of the Pilgangoora area and produces spodumene and tantalite concentrates, and the Ngungaju Plant is located to the south produces spodumene concentrate. The company owns 70% of the Mt Francisco project, which is located 50 km south-west of the Pilgangoora Project and hosts the large occurrence of outcropping pegmatites located nearby to Port Hedland. The company is also pursuing a proposed downstream joint venture (JV) for the development of an approximately 43,000 tons per annum (tpa) lithium carbonate equivalent (LCE) lithium chemical conversion facility in South Korea.
🙌 Performance (5Yr p.a)
156.73%
📊 Share price
$2.84 AUD
⛏️ MINING
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.26%
📊 Share price
$126.60 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The firm is focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its core pipeline is focused on prostate cancer, renal cancer, brain cancer (glioma) and rare diseases (hematologic cancers and bone marrow conditioning). Its pipelines include TLX591, TLX592 (alpha-RADmAb), TLX591-CDx, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx. TLX591 is a radio antibody-drug conjugate (rADC) directed at prostate-specific membrane antigen (PSMA). Its product QUANTM Irradiation System (QIS), enables production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu).
🙌 Performance (5Yr p.a)
240.77%
📊 Share price
$20.21 AUD
🧬 BIOTECHNOLOGY
Want more shares? Try these...
Qualitas Ltd. engages in real estate management services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-16. The firm offers a range of investment solutions for institutional, wholesale and retail clients. The company offers flexible capital solutions for its partners, creating long term value for shareholders and the communities in which it operates. The firm is focused on real estate private credit, opportunistic real estate private equity, income-producing commercial real estate and build-to-rent residential. The firm has two segments: Funds Management and Direct Lending. The Funds Management segment includes all the Company’s core funds management activities and includes funds management fees, performance fees and other fee income. The company also includes dividends and distributions from its co-investment and direct lending activities. The Direct Lending segment relates to the interest income and expenses relating to activities undertaken by its wholly owned subsidiaries Arch Finance and Peer Estate.
📊 Share price
$2.34 AUD
💸 FINANCIALS
Qantas Airways Ltd. engages in international and domestic air transportation services. The company is headquartered in Mascot, New South Wales. The principal activities of the Company include the operation of international and domestic air transportation services and provision of freight services and the operation of a frequent flyer loyalty program. The Company’s segments include Qantas Domestic, Qantas International, Jetstar Group, Qantas Loyalty, and Corporate. Qantas Domestic is a carrier in the Australian domestic market measured by capacity. Qantas Domestic offers on-board Wi-Fi and upgrades to the domestic lounges. Qantas International is a carrier into and out of Australia, also targeting business and premium leisure customers who value the full-service experience. Jetstar Group has domestic and international routes in Australia, joint ventures in Singapore and Japan. Qantas Loyalty is comprised of consumer and SME coalition loyalty programs. Its airline brands operate regional, domestic, and international services.
🙌 Performance (5Yr p.a)
3.48%
📊 Share price
$7.29 AUD
✈️ AIRLINES
PolarX Ltd. is a mineral exploration and development company, which focuses on gold, silver, and copper exploration and its development. The company is headquartered in Subiaco, Western Australia and currently employs 1 full-time employees. The company went IPO on 2012-12-21. The firm is focused on copper, gold, and silver projects in United States of America. Its projects include Caribou Dome Copper project, Stellar Copper-Gold project, Humboldt Range Gold-Silver project, and Fourth of July project. The Caribou Dome Copper project comprises approximately 216 contiguous state mining claims and is located adjacent to the Company’s Stellar project. The claims cover a total area of 116 square kilometers (km2). The Stellar Copper-Gold project comprises approximately 231 contiguous State Mining Claims and is located immediately adjacent to the Company’s Caribou Dome Copper Project. The claims cover a total area of 150 Km2. The Humboldt Range Gold-Silver project comprises 364 lode mining claims in Nevada in two claim groups: Black Canyon and Fourth of July and is situated between two large-scale active mines: the Florida Canyon gold mine and the Rochester silver-gold mine.
🙌 Performance (5Yr p.a)
-18.00%
📊 Share price
$0.01 AUD
⛏️ MINING